Teva Pharmaceutical Industries Ltd. (TEVA)
33.58
-0.87
(-2.53%)
USD |
NYSE |
Jun 10, 16:00
33.86
+0.28
(+0.83%)
Pre-Market: 04:24
Teva Pharmaceutical Industries EPS Diluted (TTM) : 1.346 for March 31, 2026
EPS Diluted (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (TTM) Data
| Date | Value |
|---|---|
| March 31, 2026 | 1.346 |
| December 31, 2025 | 1.218 |
| September 30, 2025 | 0.6133 |
| June 30, 2025 | -0.1461 |
| March 31, 2025 | -1.141 |
| December 31, 2024 | -1.449 |
| September 30, 2024 | -0.8508 |
| June 30, 2024 | -0.4045 |
| March 31, 2024 | -0.4272 |
| December 31, 2023 | -0.4989 |
| September 30, 2023 | -2.072 |
| June 30, 2023 | -2.083 |
| March 31, 2023 | -1.523 |
| December 31, 2022 | -2.190 |
| September 30, 2022 | -1.166 |
| June 30, 2022 | -0.9525 |
| March 31, 2022 | -0.5569 |
| December 31, 2021 | 0.3754 |
| September 30, 2021 | 0.6559 |
| June 30, 2021 | -3.576 |
| March 31, 2021 | -3.635 |
| December 31, 2020 | -3.641 |
| September 30, 2020 | -3.677 |
| June 30, 2020 | 0.0013 |
| March 31, 2020 | -0.7562 |
| Date | Value |
|---|---|
| December 31, 2019 | -0.9159 |
| September 30, 2019 | -3.849 |
| June 30, 2019 | -3.827 |
| March 31, 2019 | -3.432 |
| December 31, 2018 | -2.302 |
| September 30, 2018 | -10.92 |
| June 30, 2018 | -10.14 |
| March 31, 2018 | -15.90 |
| December 31, 2017 | -16.36 |
| September 30, 2017 | -5.921 |
| June 30, 2017 | -6.092 |
| March 31, 2017 | 0.108 |
| December 31, 2016 | 0.15 |
| September 30, 2016 | 1.72 |
| June 30, 2016 | 1.49 |
| March 31, 2016 | 1.92 |
| December 31, 2015 | 1.82 |
| September 30, 2015 | 2.07 |
| June 30, 2015 | 2.97 |
| March 31, 2015 | 3.21 |
| December 31, 2014 | 3.56 |
| September 30, 2014 | 3.221 |
| June 30, 2014 | 3.066 |
| March 31, 2014 | 1.644 |
| December 31, 2013 | 1.536 |
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| Viatris, Inc. | -0.259 |
| Johnson & Johnson | 8.649 |
| Pfizer Inc. | 1.304 |
| Novo Nordisk A/S | 4.261 |
| Novartis AG | 7.017 |